The SUCRA rankings for the incidence of NEC-associated sepsis were as follows: lactoferrin (18.7%) < prebiotics (31.3%) < EPO (42.9%) < probiotics (46.7%) < arginine (50.5%) < glutamine (77%) < placebo (83%), suggesting that lactoferrin was associated with the lowest probability of developing NEC-associated sepsis while placebo had the lowest effect. The gene discussed is LTF; the disease is Sepsis.